지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
The prevalence of SARS-CoV-2 led to inconsistent public health policies that resulted in COVID-19 containment failure. These factors resulted in increased hospitalization and death. To prevent viral spread and achieve herd immunity, the only safe and effective measure is to provide to vaccinates. Ever since the release of the SARS-CoV-2 nucleotide sequence in January of 2020, research centers and pharmaceutical companies from many countries have developed different types of vaccines including mRNA, recombinant protein, and viral vector vaccines. Prior to initiating vaccinations, phase 3 clinical trials are necessary. However, no vaccine has yet to complete a phase 3 clinical trial. Many products obtained "emergency use authorization" from governmental agencies such as WHO, FDA etc. The Korean government authorized the use of five different vaccines. The viral vector vaccine of Oxford/AstraZeneca and the Janssen showed effectiveness of 76% and 66.9%, respectively. The mRNA vaccine of Pfizer-BioNTech and Moderna showed effectiveness of 95% and 94.1%, respectively. The protein recombinant vaccine of Novavax showed an effectiveness of 90.4%. In this review, we compared the characteristics, production platform, synthesis principles, authorization, protective effects, immune responses, clinical trials and adverse effects of five different vaccines currently used in Korea. Through this review, we conceptualize the importance of selecting the optimal vaccine to prevent the COVID-19 pandemic.
목차
서론(Introduction)
본론(Main issue)
고찰(Discussion)
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Review of COVID-19 Vaccines and Their Evidence in Older Adults
Annals of geriatric medicine and research
2021 .01
-
항공종사자와 코로나바이러스감염증-19 백신 예방 접종
항공우주의학회지
2021 .04
-
Should the COVID-19 Vaccine be Administered Simultaneously with Other Vaccines?
Infection and Chemotherapy
2021 .09
-
Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic
Immune Network
2021 .02
-
Exploring the experience of developing COVID-19 vaccines in Iran
Clinical and Experimental Vaccine Research
2023 .01
-
Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey
Osong Public Health and Research Persptectives
2021 .12
-
Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country
Clinical and Experimental Vaccine Research
2021 .01
-
Inside the story about the research and development of COVID-19 vaccines
Clinical and Experimental Vaccine Research
2021 .01
-
COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021
Osong Public Health and Research Persptectives
2021 .08
-
COVID-19 Vaccination in Korea
Infection and Chemotherapy
2023 .03
-
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee
Osong Public Health and Research Persptectives
2023 .02
-
Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages
Immune Network
2021 .02
-
Benefits and Harms of COVID-19 Vaccines in Cardiovascular Disease
지질·동맥경화학회지
2023 .05
-
Association of COVID-19 vaccine attitudes and cognitions of COVID-19-related stigma with vaccine hesitancy among college students
한국간호교육학회지
2022 .08
-
Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review
Journal of Yeungnam Medical Science
2022 .04
-
Adverse events and preventive measures related to COVID-19 vaccines
Clinical and Experimental Emergency Medicine
2021 .09
-
What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
Journal of Korean Medical Science
2021 .01
-
Vaccine hesitancy in patients with COVID-19 who have back pain
Osong Public Health and Research Persptectives
2023 .04
-
Automatic Stabilizers for Excess Vaccine Stockpiles: Responsibility and Vaccine Equity in an Age of Pandemics
보건학논집
2021 .12
-
Perceptions of the COVID-19 vaccine and willingness to receive vaccination among health workers in Nigeria
Osong Public Health and Research Persptectives
2021 .08
이 논문의 저자 정보
이 논문과 함께 이용한 논문
A Review of Recent Trend of COVID-19 Infection and Correlation with Pulmonary Function
Min Woo Kim
대한의생명과학회지
2020
.09
우울증의 후성유전기전: BDNF 유전자의 히스톤 변형 및 DNA 메틸화의 역할
박성우
생명과학회지
2018
.12
CRISPR/Cas9 기반 유전자 교정 시스템과 전달 방법
송민정
,
서희정
,
송지수
BT NEWS
2017
.10
G:on mRNA: Novel Triplex pA to Enhance mRNA Stability and Translation Efficiency
Jisu WOO
,
Yoonsuk LEE
,
Sunggeun KIM
외 3명
한국생물공학회 학술대회
2024
.09
COVID-19 백신 접종 후 추적 관찰을 통한 시기능 평가
위성현
,
조현국
,
유동식
외 2명
한국안광학회지
2022
.09
최근 본 자료
댓글(0)
0